87 related articles for article (PubMed ID: 15048733)
1. CYFIP2 is highly abundant in CD4+ cells from multiple sclerosis patients and is involved in T cell adhesion.
Mayne M; Moffatt T; Kong H; McLaren PJ; Fowke KR; Becker KG; Namaka M; Schenck A; Bardoni B; Bernstein CN; Melanson M
Eur J Immunol; 2004 Apr; 34(4):1217-27. PubMed ID: 15048733
[TBL] [Abstract][Full Text] [Related]
2. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
Stüve O; Marra CM; Bar-Or A; Niino M; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Jerome KR; Cook L; Grand'Maison F; Hemmer B; Monson NL; Racke MK
Arch Neurol; 2006 Oct; 63(10):1383-7. PubMed ID: 17030653
[TBL] [Abstract][Full Text] [Related]
3. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
4. Transcript profile of CD4+ and CD8+ T cells from the bone marrow of acquired aplastic anemia patients.
Zeng W; Kajigaya S; Chen G; Risitano AM; Nunez O; Young NS
Exp Hematol; 2004 Sep; 32(9):806-14. PubMed ID: 15345281
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis.
Sun W; Hong J; Zang YC; Liu X; Zhang JZ
Int Immunol; 2006 Dec; 18(12):1691-700. PubMed ID: 17077178
[TBL] [Abstract][Full Text] [Related]
6. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients.
Lindberg RL; Hoffmann F; Mehling M; Kuhle J; Kappos L
Eur J Immunol; 2010 Mar; 40(3):888-98. PubMed ID: 20148420
[TBL] [Abstract][Full Text] [Related]
8. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
[TBL] [Abstract][Full Text] [Related]
9. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
[TBL] [Abstract][Full Text] [Related]
10. Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
Miyazaki Y; Iwabuchi K; Kikuchi S; Fukazawa T; Niino M; Hirotani M; Sasaki H; Onoé K
Mult Scler; 2008 Sep; 14(8):1044-55. PubMed ID: 18573819
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
[TBL] [Abstract][Full Text] [Related]
12. Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
Vanderlocht J; Hendriks JJ; Venken K; Stinissen P; Hellings N
J Neuroimmunol; 2006 Aug; 177(1-2):189-200. PubMed ID: 16797728
[TBL] [Abstract][Full Text] [Related]
13. Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF.
Malmeström C; Lycke J; Haghighi S; Andersen O; Carlsson L; Wadenvik H; Olsson B
J Neuroimmunol; 2008 May; 196(1-2):159-65. PubMed ID: 18396337
[TBL] [Abstract][Full Text] [Related]
14. A PD-1 polymorphism is associated with disease progression in multiple sclerosis.
Kroner A; Mehling M; Hemmer B; Rieckmann P; Toyka KV; Mäurer M; Wiendl H
Ann Neurol; 2005 Jul; 58(1):50-7. PubMed ID: 15912506
[TBL] [Abstract][Full Text] [Related]
15. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.
Frisullo G; Angelucci F; Caggiula M; Nociti V; Iorio R; Patanella AK; Sancricca C; Mirabella M; Tonali PA; Batocchi AP
J Neurosci Res; 2006 Oct; 84(5):1027-36. PubMed ID: 16865709
[TBL] [Abstract][Full Text] [Related]
16. Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T cells in patients with malignant glioma reveals differential expression of the immunologic transcriptome compared with T cells from healthy volunteers.
Learn CA; Fecci PE; Schmittling RJ; Xie W; Karikari I; Mitchell DA; Archer GE; Wei Z; Dressman H; Sampson JH
Clin Cancer Res; 2006 Dec; 12(24):7306-15. PubMed ID: 17189402
[TBL] [Abstract][Full Text] [Related]
17. Deficient Fas expression by CD4+ CCR5+ T cells in multiple sclerosis.
Julià E; Montalban X; Al-Zayat H; Issazadeh-Navikas S; Goertsches R; Martin R; Comabella M
J Neuroimmunol; 2006 Nov; 180(1-2):147-58. PubMed ID: 16899302
[TBL] [Abstract][Full Text] [Related]
18. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease.
Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Cammarota G; Mirabella M; Attilio Tonali P; Batocchi AP
Hum Immunol; 2008 Dec; 69(12):837-9. PubMed ID: 18940217
[TBL] [Abstract][Full Text] [Related]
20. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J
Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
